73 related articles for article (PubMed ID: 24192711)
1. Sustained Alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 mice.
Goll Y; Bekenstein U; Barbash S; Greenberg DS; Zangen R; Shoham S; Soreq H
Neurodegener Dis; 2014; 13(2-3):58-60. PubMed ID: 24192711
[TBL] [Abstract][Full Text] [Related]
2. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
4. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.
Cimino PJ; Yang Y; Li X; Hemingway JF; Cherne MK; Khademi SB; Fukui Y; Montine KS; Montine TJ; Keene CD
Exp Mol Pathol; 2013 Apr; 94(2):366-71. PubMed ID: 23318649
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice.
Djogo N; Jakovcevski I; Müller C; Lee HJ; Xu JC; Jakovcevski M; Kügler S; Loers G; Schachner M
Neurobiol Dis; 2013 Aug; 56():104-15. PubMed ID: 23639788
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
[TBL] [Abstract][Full Text] [Related]
11. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease.
Michaud JP; Richard KL; Rivest S
Stem Cell Rev Rep; 2012 Sep; 8(3):898-904. PubMed ID: 22374079
[TBL] [Abstract][Full Text] [Related]
13. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice.
Zhang X; Li L; Zhang X; Xie W; Li L; Yang D; Heng X; Du Y; Doody RS; Le W
Neurobiol Aging; 2013 Mar; 34(3):663-78. PubMed ID: 22795785
[TBL] [Abstract][Full Text] [Related]
14. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
15. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
[TBL] [Abstract][Full Text] [Related]
17. Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
Santuccione AC; Merlini M; Shetty A; Tackenberg C; Bali J; Ferretti MT; McAfoose J; Kulic L; Bernreuther C; Welt T; Grimm J; Glatzel M; Rajendran L; Hock C; Nitsch RM
Mol Psychiatry; 2013 Mar; 18(3):358-68. PubMed ID: 22688190
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.
Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K
Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309
[TBL] [Abstract][Full Text] [Related]
19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
20. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]